Abstract
Protein therapeutics cannot reach the brain in sufficient amounts because of their low permeability across the blood-brain barrier. Here we report a new family of bicyclic peptide shuttles, BrainBikes, capable of increasing transport of proteins, including antibody derivatives, in a human cell-based model of the blood-brain barrier.
Original language | English |
---|---|
Pages (from-to) | 7-11 |
Number of pages | 5 |
Journal | RSC Chemical Biology |
Volume | 5 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 2024 |
Keywords
- Shuttle peptides
- Barrier
- Antibodies
- Selection